Literature DB >> 218120

Presynaptic inhibitory actions of 2-substituted adenosine derivatives on neurotransmission in rat vas deferens: effects of inhibitors of adenosine uptake and deamination.

M J Muller, D M Paton.   

Abstract

In the isolated rat vas deferens, various 2-substituted adenosine derivatives and adenosine inhibited contractions elicited by field stimulation but had little effect on responses to exogenous noradrenaline. 2-Chloroadenosine, 2-bromoadenosine, 2-hydroxyadenosine and 2-fluoroadenosine were all more potent than adenosine. Theophylline antagonized the action of the 2-substituted derivatives. The inhibitory action of adenosine was potentiated by dipyridamole, 2-amino-6-[(2-hydroxy-5-nitro)benzylthio]-9-beta-D-ribofuranosylpurine (HNBTG) or 2'-deoxycoformycin while that of 2-choloroadenosine was not altered by any of these drugs or by phenoxybenzamine, atropine or indomethacin. Pretreatment of the vas deferens with both HNBTG and 2'-deoxycoformycin eliminated the difference in inhibitory potency between adenosine and 2-chloroadenosine. These results indicate that 2-substituted adenosine derivatives, like adenosine, produce inhibition of transmission by acting on a presynaptic site which can be blocked by theophylline. The high apparent potency of 2-chloroadenosine compared to adenosine appears to be due to the former being neither taken up nor deaminated, while the apparent potency of adenosine is masked by uptake and deamination in this tissue.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 218120     DOI: 10.1007/bf00515589

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  Pharmacological differences of non-adrenergic inhibitory response and of ATP-induced relaxation in guineq-pig tracheal strip-chains.

Authors:  Y Kamikawa; Y Shimo
Journal:  J Pharm Pharmacol       Date:  1976-11       Impact factor: 3.765

2.  Enzymatic deamination and vasodepressor effects of adenosine analogs.

Authors:  D A CLARKE; J DAVOLL; F S PHILIPS; G B BROWN
Journal:  J Pharmacol Exp Ther       Date:  1952-11       Impact factor: 4.030

Review 3.  Membrane transport of purine and pyrimidine bases and nucleosides in animal cells.

Authors:  R D Berlin; J M Oliver
Journal:  Int Rev Cytol       Date:  1975

4.  Presynaptic inhibitory actions of adenine nucleotides and adenosine on neurotransmission in the rat vas deferens.

Authors:  A S Clanachan; A Johns; D M Paton
Journal:  Neuroscience       Date:  1977       Impact factor: 3.590

5.  Effects of adenosine on adrenergic neurotransmission; prejunctional inhibition and postjunctional enhancement.

Authors:  P Hedqvist; B B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-06       Impact factor: 3.000

6.  The effect of number of stimuli and rate of stimulation on the inhibition by PGE1 of adrenergic transmission.

Authors:  P Illés; P Hadházy; Z Torma; E S Vizi; J Knoll
Journal:  Eur J Pharmacol       Date:  1973-10       Impact factor: 4.432

7.  Catabolism of adenine nucleotides by the isolated perfused rat heart.

Authors:  H P Baer; G I Drummond
Journal:  Proc Soc Exp Biol Med       Date:  1968-01

8.  Studies on adenosine deaminase. I. Purification and properties of ox heart adenosine deaminase.

Authors:  M Rockwell; M H Maguire
Journal:  Mol Pharmacol       Date:  1966-11       Impact factor: 4.436

9.  Inhibitory effects of adenine nucleotide analogs on the isolated guinea-pig taenia coli.

Authors:  D G Satchell; M H Maguire
Journal:  J Pharmacol Exp Ther       Date:  1975-12       Impact factor: 4.030

10.  Studies on the coronary dilator actions of some adenosine analogues.

Authors:  L B Cobbin; R Einstein; M H Maguire
Journal:  Br J Pharmacol       Date:  1974-01       Impact factor: 8.739

View more
  15 in total

1.  Effect of adenosine and adenosine analogs on [14C]aminopyrine accumulation by rabbit parietal cells.

Authors:  S Ota; H Hiraishi; A Terano; H Mutoh; Y Kurachi; T Shimada; K J Ivey; T Sugimoto
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

2.  Facilitatory and inhibitory modulation by endogenous adenosine of noradrenaline release in the epididymal portion of rat vas deferens.

Authors:  J Gonçalves; G Queiroz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

3.  Therapeutic concentrations of diazepam potentiate the effects of adenosine on isolated cardiac and smooth muscle [proceedings].

Authors:  A S Clanachan; R J Marshall
Journal:  Br J Pharmacol       Date:  1980-01       Impact factor: 8.739

4.  Hypothermia-induced supersensitivity to adenosine for responses mediated via A1-receptors but not A2-receptors.

Authors:  K J Broadley; S Broome; D M Paton
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

5.  Potentiation of the effects of adenosine on isolated cardiac and smooth muscle by diazepam.

Authors:  A S Clanachan; R J Marshall
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

6.  Indirect evidence that purinergic modulation of perivascular adrenergic neurotransmission in the portal vein is a physiological process.

Authors:  G Burnstock; R Crowe; C Kennedy; J Török
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

7.  Effects of metoclopramide and isoprenaline in the rat vas deferens; interactions with alpha-adrenoceptors.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

8.  Release of norepinephrine and dopamine from brain vesicular preparations: effects of adenosine analogues.

Authors:  R P Ebstein; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1982-09       Impact factor: 5.046

9.  Effects of adenosine, adenosine triphosphate and structural analogues on glucagon secretion from the perfused pancreas of rat in vitro.

Authors:  J Chapal; M M Loubatières-Mariani; M Roye; A Zerbib
Journal:  Br J Pharmacol       Date:  1984-12       Impact factor: 8.739

10.  PACPX--a substituted xanthine--antagonizes both the A1 and A2 subclasses of the P1-purinoceptor: antagonism of the A2 subclass is competitive but antagonism of the A1 subclass is not.

Authors:  G Burnstock; C H Hoyle
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.